martes, 19 de marzo de 2024

Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act

https://www.federalregister.gov/public-inspection/2024-05801/drug-products-or-categories-of-drug-products-that-present-demonstrable-difficulties-for-compounding?utm_medium=email&utm_source=govdelivery

No hay comentarios: